_ OUR NEWS
OCULUS BIOMED NEWS
November 27, 2023
OBM is delighted to welcome Roger to the executive team. He brings significant technical skill and industry experience to the company. Roger has more than 30 […]
November 1, 2023
OBM recently attended Australias premier biotechnology conference in Brisbane – represented by CEO Andrew Coloretti & Non-Executive Director Michelle Gallaher. The conference included valuable one-on-one private […]
October 9, 2023
Oculus BioMed (OBM) an ophthalmology focused biotechnology company, entered into a collaboration agreement with CERA – Centre for Eye Research Australia regarding the development of a therapeutic […]
October 1, 2023
OBM is delighted to welcome Michelle to the Board. She is an exceptional person and professional and brings significant industry experience and skill to the company. […]
August 28, 2023
OBM’s CEO was invited by Dr. Rupesh Agrawal – Deputy Research Head at Singapore’s Tan Tock Seng Hospital (TTSH) to tour the Ophthalmology department research facilities […]
August 28, 2023
OBM’s CEO & CSO held meetings with the company’s key business and scientific partners –ACRO Biomedical’s & Krisan Biotech CEO’s (D.J. Hsieh & Jamie Hung respectively) […]